- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Veradermics Inc (MANE)
Track today's live Veradermics (MANE) share price, performance and key data on this page with our current NYSE:MANE stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Veradermics share price on the NYSE exchange. Use the dropdown to switch exchange for the MANE share price, head to our technical summary section, which provides analysis on Veradermics share price buy/sell indicators using real-time data (or discuss the Veradermics (MANE) stock price today with other investors in the Veradermics NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE:MANE share price (ISIN: US9229671048) to enhance your trading decisions with our free investment tools and resources.
What Is the Veradermics Inc Share Price Today?
The Veradermics share price today is 110.75.
What Is the Stock Symbol for Veradermics Inc
The stock symbol (or 'ticker') for Veradermics Inc is "MANE."
What Stock Exchange Does Veradermics Inc Trade On?
Veradermics Inc is listed and trades on the NYSE stock exchange.
Is Veradermics Inc a Good Stock to Buy?
Determining whether Veradermics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NYSE:MANE share price (ISIN: US9229671048) to enhance your trading decisions with our free investment tools and resources.
What Is the Veradermics Inc Share Price Today?
The Veradermics share price today is 110.75.
What Is the Stock Symbol for Veradermics Inc
The stock symbol (or 'ticker') for Veradermics Inc is "MANE."
What Stock Exchange Does Veradermics Inc Trade On?
Veradermics Inc is listed and trades on the NYSE stock exchange.
Is Veradermics Inc a Good Stock to Buy?
Determining whether Veradermics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
NYSE
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
107.67
113.91
52 wk Range
32.00
131.24
MANE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
107.67113.91
52 wk Range
32.00131.24
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MANE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
163.50
Upside
+47.63%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 163.50
(+47.63% Upside)
Earnings
Latest Release
12/05/2026
EPS / Forecast
-1.26 / --
Revenue / Forecast
-- / --
Compare MANE to Peers and Sector
Metrics to compare | MANE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMANEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −46.8x | 5.9x | −0.4x | |
PEG Ratio | - | −0.16 | 0.00 | |
Price/Book | 11.8x | 5.8x | 2.6x | |
Price / LTM Sales | - | 6.8x | 3.1x | |
Upside (Analyst Target) | 46.0% | 43.9% | 48.5% | |
Fair Value Upside | Unlock | −2.4% | 5.8% | Unlock |
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was incorporated in 2019 and is headquartered in New Haven, Connecticut.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Veradermics (NYSE: MANE) Share Price Today?
The Veradermics stock price today is 110.75 USD.
What Stock Exchange Does Veradermics (MANE) Trade On?
Veradermics is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for Veradermics?
The stock symbol (also called a 'ticker') for Veradermics is "MANE."
What Is the Current Veradermics Market Capitalisation?
As of today, Veradermics (NYSE: MANE) market cap is 4.78B USD.
What Is Veradermics's (MANE) Earnings Per Share (TTM)?
The Veradermics EPS is currently -15.84 (Trailing Twelve Months).
When Is the Next Veradermics Earnings Date?
Veradermics's next earnings report will be released on 02/09/2026.
Is MANE a Buy or Sell From a Technical Analyst Perspective?
Based on today's Veradermics moving averages and other technical indicators, the daily buy/sell signal for MANE stock is Strong Buy.
How Many Times Has Veradermics Stock Split?
Veradermics has split 0 times. (See the MANE stock split history page for full effective split date and price information.)
What is the current trading status of Veradermics (NYSE: MANE)?
As of 11/08/2026, Veradermics (MANE) is trading at a share price of 110.75 USD, with a previous close of 114.39 USD. The stock has fluctuated within a day range of 107.67 USD to 113.91 USD, while its 52-week range spans from 32.00 USD to 131.24 USD.
What Is Veradermics (MANE) Price Target According to Analysts?
The average 12-month price target for Veradermics is 163.50 USD, with a high estimate of 182 USD and a low estimate of 135 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +47.63% Upside potential.
What Is the MANE Premarket Price?
MANE's last pre-market stock price is 112.41 USD. The pre-market share volume is 7,500.00, and the stock has decreased by -1.98, or -1.73%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.